H2Stem cell therapy

N/A

Report date: 2025/01/26 17:35:33

Base Information

Drug NameH2Stem cell therapy
Drug Alias Namehepatobiliary progenitor stem cell therapy (Promethera Biosciences)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hepatogenic potential stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellaion SA
China Registration ClassN/A

Develop Information

Active CompaniesCellaion SA
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A